CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 1.201
EU - Europa 578
AS - Asia 208
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 1.991
Nazione #
US - Stati Uniti d'America 1.200
CN - Cina 185
SE - Svezia 170
DE - Germania 165
IT - Italia 119
GB - Regno Unito 46
RU - Federazione Russa 45
SG - Singapore 14
FR - Francia 12
BE - Belgio 5
IN - India 4
PL - Polonia 4
IE - Irlanda 3
CZ - Repubblica Ceca 2
EU - Europa 2
FI - Finlandia 2
VN - Vietnam 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
CA - Canada 1
CH - Svizzera 1
DK - Danimarca 1
IM - Isola di Man 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
UG - Uganda 1
Totale 1.991
Città #
Chandler 173
Ashburn 158
Nyköping 136
Fairfield 114
New York 56
Houston 51
Cambridge 50
Beijing 49
Seattle 48
Dearborn 44
Woodbridge 43
Wilmington 38
Nanjing 35
Lawrence 34
Roxbury 32
Bari 28
Des Moines 25
Ann Arbor 23
Redwood City 22
Brooklyn 20
Shenyang 13
Boardman 12
Nanchang 10
Inglewood 9
San Diego 9
Changsha 7
Jinan 7
Guangzhou 6
Milan 6
Brussels 5
Hebei 5
Paris 5
San Francisco 5
Bolzano 4
Jiaxing 4
Pune 4
Singapore 4
Washington 4
Bitonto 3
Dublin 3
Hangzhou 3
Hefei 3
Jacksonville 3
Kunming 3
Nürnberg 3
Princeton 3
Taranto 3
Tianjin 3
Acquaviva delle Fonti 2
Cerignola 2
Chengdu 2
Cutrofiano 2
Fuzhou 2
Massafra 2
Nardò 2
Ningbo 2
Nuremberg 2
Olomouc 2
Shanghai 2
Shaoxing 2
Shenzhen 2
Wuhan 2
Acton 1
Amsterdam 1
Arzano 1
Auckland 1
Belpasso 1
Chicago 1
Chiswick 1
Chongqing 1
Dong Ket 1
Douglas 1
Edinburgh 1
Frosinone 1
Helsinki 1
Ho Chi Minh City 1
Jinhua 1
Kampala 1
Lecce 1
Los Angeles 1
Lugano 1
Melendugno 1
Miami 1
Mountain View 1
Naples 1
Napoli 1
Niva 1
Norwalk 1
Putignano 1
Quanzhou 1
Reggio Calabria 1
Rogliano 1
Rome 1
San Jose 1
San Pietro in Casale 1
Sarno 1
Scandiano 1
Taizhou 1
Tokyo 1
Toronto 1
Totale 1.394
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 106
Wasp immunotherapy induced long-term and IgG4-independent protection 84
Test di proliferazione linfocitaria nella diagnosi delle reazioni ritardate a farmaci 80
null 74
Cost-effectiveness of grass pollen allergen immunotherapy in adults 74
L'allergia alimentare della Dieta Mediterranea 72
null 72
null 71
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità. 68
null 68
Allergia al latte. Studio sulla risposta IgE-mediata in vivo verso frazioni proteiche di latte di capra Garganica 67
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 65
null 64
null 60
Terapia dell'asma severo con omalizumab: uno studio real life in 51 pazienti. 59
Desensitization in Iron Product Allergy 59
Omalizumab nel trattamento dell'allergia alimentare 55
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases 52
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) non competitive inhibition by the Cys-LT1 receptor antagonists montelukast 52
Novel inhibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 49
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study 44
Fennel (Foeniculum vulgare) allergy. 43
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 42
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 42
Characteristics and treatment regimens across ERS SHARP severe asthma registries 40
Fennel (Phoeniculum vulgare): a major allergen of the Mediterranean Diet 38
Composizione pollinica dell'atmosfera di Barletta 38
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenetyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties 38
La disfunzione psicosomatica delle corde vocali 38
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 38
The lymphocyte proliferation test (LPT) in the diagnosis of critical cases of delayed drug allergy. 36
Sensitivity and specificity of new Vespa crabro allergen extract in patients with anaphylaxis to V. crabro. 34
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 30
Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management 29
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 29
Recognition of novel Mediterranean food allergens:allergy to artichoke 28
Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review 21
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 21
Importance of Specific IgE/Total IgE Ratio in Disambiguating Amoxicillin Allergy Diagnosis in a Real-Life Setting 20
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report 19
Long-term treatment of refractory severe urticaria by omalizumab: analysis of two cases. 17
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 9
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 8
SANI-Severe Asthma Network in Italy: A way forward to monitor severe asthma 8
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 2
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 1
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 1
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 1
Totale 2.066
Categoria #
all - tutte 9.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020387 71 13 20 29 16 47 43 21 17 43 43 24
2020/2021273 13 27 16 32 28 38 26 27 12 23 14 17
2021/2022280 7 22 4 3 11 36 11 15 9 15 42 105
2022/2023462 48 109 40 13 32 65 7 32 91 1 16 8
2023/2024290 11 31 14 18 14 121 30 22 5 2 2 20
2024/202536 36 0 0 0 0 0 0 0 0 0 0 0
Totale 2.066